Latest / Community Health Media
Dr. Jason Mouabbi & Dr. Eric Singhi - ADCs in Breast & Lung Cancer
What happens when breast and thoracic oncology collide over the future of ADCs?
In this cross-specialty conversation, Dr. Jason Mouabbi and Dr. Eric Singhi explore how antibody-drug conjugates are reshaping both breast and lung cancer treatment. From T-DXd and datopotamab deruxtecan to HER2-low disease, EGFR-mutated NSCLC, ILD management, sequencing strategies, and the future of combination ADC therapy — this episode dives deep into the rapidly evolving world of precision oncology.
They discuss:
• Why ADCs are transforming metastatic care
• Managing ILD, stomatitis, ocular toxicity, and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.